2009 Annual Meeting | Diagnostic Dilemmas in Multiple Sclerosis

Date Saturday 05/02/09

Time 09:00 AM - 12:45 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Mark Keegan, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the broad spectrum of CNS demyelinating diseases, inflammatory, other myelopathies, and the differential diagnosis of mimickers of these conditions.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Resident

Event Timeline
09:00 AM - 09:40 AM		Spectrum of CNS Inflammatory Demyelinating Disorders Mark Keegan, MD, FAAN
09:40 AM - 10:20 AM		Approach to Acute Myelopathy Brian G. Weinshenker, MD, FAAN
10:20 AM - 10:30 AM		Questions and Answers
10:30 AM - 10:45 AM		Break
10:30 AM - 10:50 PM		Break
10:50 AM - 11:30 AM		Mimickers of Multiple Sclerosis Nuhad Abou Zeid, MD
11:30 AM - 11:45 PM		Questions and Answers
11:45 AM - 12:30 PM		Open Case Discussions
12:30 PM - 12:45 PM		Questions and Answers

Faculty Disclosures
Brian G. Weinshenker, MD, FAAN	Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Mark Keegan, MD, FAAN	Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Nuhad Abou Zeid, MD	No disclosure on file

��ɫ��

��ɫ��